Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 25 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is Y  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
N. Yurgin, Secnik, K., and Lage, M. J., “Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK”, J Diabetes Complications, vol. 22, pp. 235-40, 2008.
O. Yu, Azoulay, L., Yin, H., Filion, K. B., and Suissa, S., “Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia”, Am J Med, vol. 131, pp. 317.e11-317.e22, 2018.
O. H. Yu, Filion, K. B., Azoulay, L., Patenaude, V., Majdan, A., and Suissa, S., “Incretin-based drugs and the risk of congestive heart failure”, Diabetes Care, vol. 38, pp. 277-84, 2015.
O. H. Yu, Yin, H., and Azoulay, L., “The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death”, Can J Diabetes, vol. 39, pp. 383-9, 2015.
J. Yu, Tang, J., Li, Z., Sajjan, S., O'Regan, C., Modi, A., and Sazonov, V., “History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis”, Int J Womens Health, vol. 7, pp. 913-8, 2015.
D. Yu, Jordan, K. P., Bedson, J., Englund, M., Blyth, F., Turkiewicz, A., Prieto-Alhambra, D., and Peat, G., “Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013”, Rheumatology (Oxford), vol. 56, pp. 1902-1917, 2017.
D. Yu, Jordan, K. P., Snell, K. I. E., Riley, R. D., Bedson, J., Edwards, J. J., Mallen, C. D., Tan, V., Ukachukwu, V., Prieto-Alhambra, D., Walker, C., and Peat, G., “Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink”, Ann Rheum Dis, 2018.
D. Yu, Jordan, K. P., and Peat, G., “Underrecording of osteoarthritis in United Kingdom primary care electronic health record data”, Clin Epidemiol, vol. 10, pp. 1195-1201, 2018.
J. P. Yska, van Roon, E. N., de Boer, A., Leufkens, H. G., Wilffert, B., de Heide, L. J., de Vries, F., and Lalmohamed, A., “Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom”, JAMA Surg, vol. 150, pp. 1126-33, 2015.
G. J. Young, Harrison, S., Turner, E. L., Walsh, E. I., Oliver, S. E., Ben-Shlomo, Y., Evans, S., Lane, J. A., Neal, D. E., Hamdy, F. C., Donovan, J. L., Martin, R. M., and Metcalfe, C., “Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study”, BMJ Open, vol. 7, p. e017729, 2017.
M. Yong, Schoonen, W. M., Li, L., Kanas, G., Coalson, J., Mowat, F., Fryzek, J., and Kaye, J. A., “Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database”, Br J Haematol, vol. 149, pp. 855-64, 2010.
Z. Z. N. Yiu, Parisi, R., Lunt, M., Warren, R. B., Griffiths, C. E. M., Langan, S. M., and Ashcroft, D. M., “Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink”, Br J Dermatol, 2020.
Y. Ye, Jiang, B., Manne, S., Moses, P. L., Almansa, C., Bennett, D., Dolin, P., and Ford, A. C., “Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom”, Gut, 2020.
T. A. Yates, Tomlinson, L. A., Bhaskaran, K., Langan, S., Thomas, S., Smeeth, L., and Douglas, I. J., “Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort”, PLoS Med, vol. 14, p. e1002457, 2017.
E. A. Yanni, Ferreira, G., Guennec, M., Y. Hahi, E., A. Ghachi, E., Haguinet, F., Espie, E., and Bianco, V., “Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012”, BMJ Open, vol. 8, p. e020528, 2018.
B. Yang, Hagberg, K. W., Chen, J., Sahasrabuddhe, V. V., Graubard, B. I., Jick, S., and McGlynn, K. A., “Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink”, Br J Cancer, vol. 115, pp. 85-9, 2016.
B. Yang, Petrick, J. L., Chen, J., Hagberg, K. W., Sahasrabuddhe, V. V., Graubard, B. I., Jick, S., and McGlynn, K. A., “Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink”, Cancer Epidemiol, vol. 43, pp. 105-11, 2016.
Y. X. Yang, Hennessy, S., and Lewis, J. D., “Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients”, Gastroenterology, vol. 127, pp. 1044-50, 2004.
Y. X. Yang, Hennessy, S., and Lewis, J. D., “Type 2 diabetes mellitus and the risk of colorectal cancer”, Clin Gastroenterol Hepatol, vol. 3, pp. 587-94, 2005.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sarkar, M., and Lewis, J. D., “Chronic statin therapy and the risk of colorectal cancer”, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sedarat, A., and Lewis, J. D., “Chronic proton pump inhibitor therapy and the risk of colorectal cancer”, Gastroenterology, vol. 133, pp. 748-54, 2007.
C. C. Yang, Jick, S. S., and Jick, H., “Statins and the risk of idiopathic venous thromboembolism”, Br J Clin Pharmacol, vol. 53, pp. 101-5, 2002.
C. C. Yang, Jick, S. S., and Jick, H., “Lipid-lowering drugs and the risk of depression and suicidal behavior”, Arch Intern Med, vol. 163, pp. 1926-32, 2003.
C. C. Yang, Jick, S. S., and Testa, M. A., “Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics”, Br J Clin Pharmacol, vol. 56, pp. 84-91, 2003.
C. C. Yang, Jick, S. S., and Testa, M. A., “Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation”, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
[Page last reviewed 7 September 2020]